Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Clasificación en acciones #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Precio por acción
$9.44
Capitalización bursátil
$355.41M
Cambio (1 día)
-0.63%
Cambio (1 año)
91.48%
País
US
Comercio BioAge Labs Inc. (BIOA)

Categoría

Precio BIOA con Capital del mercado a B
BioAge Labs Inc. BioAge Labs Inc.
BIOA
$9.44
Capitalización de mercado de BioAge Labs Inc.(BIOA)
Capitalización bursátil: $355.41M
A fecha de September 2026, BioAge Labs Inc. tiene una capitalización de mercado de $355.41M. Esto convierte a BioAge Labs Inc. en la 15446th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de BioAge Labs Inc. desde 2024 hasta 2026
BIOA en comparación con los más populares 5 títulos stocks
Precio por BIOA Activo B Capital del mercado en B Resultados
BioAge Labs Inc. BioAge Labs Inc.
$141,484 $355.41M
$5.327T +1,498,666.31%
BioAge Labs Inc. BioAge Labs Inc.
$123,371 $355.41M
$4.645T +1,306,797.13%
BioAge Labs Inc. BioAge Labs Inc.
$108,109 $355.41M
$4.070T +1,145,121.34%
BioAge Labs Inc. BioAge Labs Inc.
$100,521 $355.41M
$3.785T +1,064,741.47%
BioAge Labs Inc. BioAge Labs Inc.
$74,107.57 $355.41M
$2.790T +784,937.80%